Increasingly ‘library free’ analysis of DIA data has become a popular alternative to analyzing DIA data. Being able to skip DDA acquisition for library generation greatly simplifies the workflow. A downside of this approach is that it can be significantly slower than performing a classical DIA analysis with an available library.

Presenter: Alexandros Pachos

Date: Tuesday, June 6
Topic area: Artificial Intelligence in MS Instrumentation and Applications

At Biognosys, we believe that we can dramatically improve human health by deciphering the biological complexity of diseases. By providing access to the proteome on all levels, we enable life science researchers and drug hunters to unlock true discoveries.

We push the boundaries of what is possible with our proteomics solutions to help usher in a new age of bioengineering and precision medicine.

When we look at the proteome differently, we envision a better world!

To learn more about our vision, mission, and values, watch our new corporate video and visit: biognosys.com/our-story/

In this series, our Software Product Manager, Monika Puchalska, guides you through every aspect of Spectronaut – from downloading and setting up the software to the many ways to visualize and analyze your data.

Whether you are a seasoned user or just getting started, our tutorials cover a wide range of topics to ensure you can make the most of Spectronaut’s capabilities.

Preclinical drug development involves in-vivo discovery studies whereby essential model organisms, including mouse and rat help to understand human biology and disease. Despite genetic similarities, distinctions in gene expression between humans and relevant model organisms underscore the challenge of translatability.

New: Spectronaut^® 19

Unlock Your Data's True Story

New: Spectronaut^® 19

Unlock Your Data's True Story

Learn More